Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Corteva (CTVA) Research & Development (2018 - 2025)

Corteva (CTVA) has 8 years of Research & Development data on record, last reported at $413.0 million in Q4 2025.

  • For Q4 2025, Research & Development rose 13.15% year-over-year to $413.0 million; the TTM value through Dec 2025 reached $1.5 billion, up 5.14%, while the annual FY2025 figure was $1.5 billion, 5.14% up from the prior year.
  • Research & Development reached $413.0 million in Q4 2025 per CTVA's latest filing, up from $351.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $413.0 million in Q4 2025 and bottomed at $268.0 million in Q1 2022.
  • Average Research & Development over 5 years is $330.8 million, with a median of $333.5 million recorded in 2023.
  • Peak YoY movement for Research & Development: decreased 4.63% in 2022, then rose 17.91% in 2023.
  • A 5-year view of Research & Development shows it stood at $316.0 million in 2021, then grew by 7.59% to $340.0 million in 2022, then increased by 5.0% to $357.0 million in 2023, then increased by 2.24% to $365.0 million in 2024, then grew by 13.15% to $413.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $413.0 million in Q4 2025, $351.0 million in Q3 2025, and $375.0 million in Q2 2025.